130 related articles for article (PubMed ID: 27042847)
1. Impact of early CMV reactivation in cord blood stem cell recipients in the current era.
Ramanathan M; Teira P; Battiwalla M; Barrett J; Ahn KW; Chen M; Green J; Laughlin M; Lazarus HM; Marks D; Saad A; Seftel M; Saber W; Savani B; Waller EK; Wingard J; Auletta JJ; Lindemans CA; Boeckh M; Riches ML
Bone Marrow Transplant; 2016 Aug; 51(8):1113-20. PubMed ID: 27042847
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
3. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia.
Green ML; Leisenring WM; Xie H; Walter RB; Mielcarek M; Sandmaier BM; Riddell SR; Boeckh M
Blood; 2013 Aug; 122(7):1316-24. PubMed ID: 23744585
[TBL] [Abstract][Full Text] [Related]
4. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia.
Inagaki J; Noguchi M; Kurauchi K; Tanioka S; Fukano R; Okamura J
Biol Blood Marrow Transplant; 2016 Feb; 22(2):300-306. PubMed ID: 26371373
[TBL] [Abstract][Full Text] [Related]
5. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.
Teira P; Battiwalla M; Ramanathan M; Barrett AJ; Ahn KW; Chen M; Green JS; Saad A; Antin JH; Savani BN; Lazarus HM; Seftel M; Saber W; Marks D; Aljurf M; Norkin M; Wingard JR; Lindemans CA; Boeckh M; Riches ML; Auletta JJ
Blood; 2016 May; 127(20):2427-38. PubMed ID: 26884374
[TBL] [Abstract][Full Text] [Related]
6. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
8. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT.
Schmidt-Hieber M; Labopin M; Beelen D; Volin L; Ehninger G; Finke J; Socié G; Schwerdtfeger R; Kröger N; Ganser A; Niederwieser D; Polge E; Blau IW; Mohty M
Blood; 2013 Nov; 122(19):3359-64. PubMed ID: 24037724
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children.
Jeljeli M; Guérin-El Khourouj V; Porcher R; Fahd M; Leveillé S; Yakouben K; Ouachée-Chardin M; LeGoff J; Cordeiro DJ; Pédron B; Baruchel A; Dalle JH; Sterkers G
Br J Haematol; 2014 Jul; 166(2):229-39. PubMed ID: 24702221
[TBL] [Abstract][Full Text] [Related]
10. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
[TBL] [Abstract][Full Text] [Related]
11. The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors.
Busca A; Passera R; Pini M; Zallio F; Dellacasa C; Audisio E; Giaccone L; Maffini E; Costa C; Cavallo R; Bruno B
Am J Hematol; 2015 Jun; 90(6):E117-21. PubMed ID: 25752810
[TBL] [Abstract][Full Text] [Related]
12. [Cytomegalovirus reactivation after allogeneic stem cell transplantation reduces the risk of relapse in patients with acute myeloid leukemia].
Takenaka K
Rinsho Ketsueki; 2015 Jul; 56(7):825-30. PubMed ID: 26251145
[TBL] [Abstract][Full Text] [Related]
13. Favorable Effect of Cytomegalovirus Reactivation on Outcomes in Cord Blood Transplant and Its Differences Among Disease Risk or Type.
Yokoyama H; Takenaka K; Nishida T; Seo S; Shinohara A; Uchida N; Tanaka M; Takahashi S; Onizuka M; Kozai Y; Yasuhiro S; Ozawa Y; Katsuoka Y; Doki N; Sawa M; Kimura T; Kanda J; Fukuda T; Atsuta Y; Nakasone H;
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1363-1370. PubMed ID: 32311477
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients.
Park M; Lee YH; Lee SH; Yoo KH; Sung KW; Koo HH; Lee JW; Kang HJ; Park KD; Shin HY; Ahn HS; Lee JW; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Baek HJ; Kook H; Hwang TJ; Lee JM; Hah JO; Lim YJ; Park JE; Lyu CJ; Lim YT; Chong SY; Oh D;
Ann Hematol; 2015 Mar; 94(3):481-9. PubMed ID: 25417830
[TBL] [Abstract][Full Text] [Related]
15. Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.
Beck JC; Wagner JE; DeFor TE; Brunstein CG; Schleiss MR; Young JA; Weisdorf DH; Cooley S; Miller JS; Verneris MR
Biol Blood Marrow Transplant; 2010 Feb; 16(2):215-22. PubMed ID: 19786112
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
17. Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission.
Yoon JH; Lee S; Kim HJ; Jeon YW; Lee SE; Cho BS; Lee DG; Eom KS; Kim YJ; Min CK; Cho SG; Min WS; Lee JW
Oncotarget; 2016 Mar; 7(13):17230-41. PubMed ID: 26883100
[TBL] [Abstract][Full Text] [Related]
18. Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.
Nakamura R; Gendzekhadze K; Palmer J; Tsai NC; Mokhtari S; Forman SJ; Zaia JA; Senitzer D; Marcucci G; Stein A
Leuk Res; 2019 Dec; 87():106230. PubMed ID: 31644966
[TBL] [Abstract][Full Text] [Related]
19. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
Atsuta Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kasai M; Fukuda T; Azuma H; Takanashi M; Okamoto S; Tsuchida M; Kawa K; Morishima Y; Kodera Y; Kato S;
Blood; 2009 Feb; 113(8):1631-8. PubMed ID: 19104080
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
Ruggeri A; Labopin M; Sanz G; Piemontese S; Arcese W; Bacigalupo A; Blaise D; Bosi A; Huang H; Karakasis D; Koc Y; Michallet M; Picardi A; Sanz J; Santarone S; Sengelov H; Sierra J; Vincent L; Volt F; Nagler A; Gluckman E; Ciceri F; Rocha V; Mohty M; ;
Leukemia; 2015 Sep; 29(9):1891-900. PubMed ID: 25882700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]